Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug;26(8):1931-41.
doi: 10.1007/s11095-009-9920-4. Epub 2009 Jun 5.

A potential targeting gene vector based on biotinylated polyethyleneimine/avidin bioconjugates

Affiliations

A potential targeting gene vector based on biotinylated polyethyleneimine/avidin bioconjugates

Xuan Zeng et al. Pharm Res. 2009 Aug.

Abstract

Purpose: To improve the gene delivery efficiency and safety of non-viral vector in liver cells, avidin, which exhibited good biocompatibility and remarkable accumulation in liver, was bioconjugated with biotinylated polyethylenimine to obtain a novel gene vector.

Materials and methods: Biotinylated polyethyleneimine/avidin bioconjugate (ABP) was synthesized through grafting biotin to high molecular weight branched polyethylenimine (PEI, 25 kDa) and then bioconjugating with avidin by the biotin-avidin interaction. Physiochemical characteristics of ABP/pDNA complexes were analyzed, and in vitro cytotoxicity and transfection of ABP were also evaluated in HepG2, Hela and 293 T cells by using 25 kDa PEI as the control.

Results: It was found that ABP was able to condense pDNA efficiently at N/P ratio of 4. The particle sizes of ABP/pDNA complexes were less than 220 nm, and the average surface charges were around 27 mV at the N/P ratio ranging from 2 to 60. Among three different cell lines, ABP and its DNA complexes demonstrated much lower cytotoxicity and higher transfection efficacy in HepG2 cells as compared with 25 kDa PEI.

Conclusion: ABP presented higher transfection efficacy and safety in HepG2 cells due to the biocompatibility of avidin and the specific interactions between avidin and HepG2 cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Bioconjug Chem. 2000 Sep-Oct;11(5):637-45 - PubMed
    1. J Control Release. 2004 Feb 20;95(1):133-41 - PubMed
    1. J Control Release. 2002 Apr 23;80(1-3):273-82 - PubMed
    1. Langmuir. 2005 Apr 26;21(9):4066-70 - PubMed
    1. J Control Release. 1999 Aug 5;60(2-3):149-60 - PubMed

LinkOut - more resources